US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist
  • 1.250
  • -0.290-18.83%
Close Mar 27 16:00 ET
  • 1.220
  • -0.030-2.40%
Post 20:01 ET
1.82MMarket Cap-0.01P/E (TTM)

Aptevo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-102.77%-23.79M
-9.63%-5.76M
16.31%-5.22M
-28.11%-6.15M
-245.66%-6.65M
44.20%-11.73M
11.55%-5.25M
9.51%-6.24M
-56.45%-4.8M
189.23%4.57M
Net income from continuing operations
-38.59%-24.13M
-6.93%-6.31M
19.45%-5.1M
25.98%-5.88M
-346.45%-6.83M
-316.91%-17.41M
-27.17%-5.9M
17.15%-6.33M
-128.38%-7.95M
136.03%2.77M
Depreciation and amortization
-37.92%352K
-38.79%71K
-31.71%84K
-39.33%91K
-40.45%106K
-37.07%567K
-27.95%116K
-44.59%123K
-45.65%150K
-26.45%178K
Other non cash items
----
----
----
----
----
100.03%10K
--0
--0
--0
-99.41%10K
Change In working capital
-136.96%-1.08M
214.77%554K
27.01%-354K
-125.06%-634K
-193.04%-642K
35.77%2.91M
109.57%176K
-348.72%-485K
-32.32%2.53M
1,280.00%690K
-Change in receivables
--0
--0
--0
--0
--0
114.78%2.5M
--0
--0
--0
354.55%2.5M
-Change in prepaid assets
41.83%217K
314.38%313K
-118.13%-746K
-78.95%312K
140.19%338K
-56.90%153K
46.91%-146K
44.66%-342K
55.67%1.48M
-384.12%-841K
-Change in payables and accrued expense
-296.33%-1.02M
-16.71%324K
710.53%464K
-178.90%-879K
-1.87%-926K
231.47%518K
-60.67%389K
-108.82%-76K
176.99%1.11M
-13.91%-909K
-Change in other current assets
16.59%492K
18.02%131K
17.92%125K
18.63%121K
11.65%115K
-35.38%422K
5.71%111K
1.92%106K
-38.55%102K
-62.95%103K
-Change in other current liabilities
-12.61%-768K
-20.22%-214K
-13.87%-197K
-11.90%-188K
-3.68%-169K
-286.34%-682K
-12.66%-178K
-13.07%-173K
-117.63%-168K
40.94%-163K
Cash from discontinued investing activities
Operating cash flow
-102.77%-23.79M
-9.63%-5.76M
16.31%-5.22M
-28.11%-6.15M
-245.66%-6.65M
44.20%-11.73M
11.55%-5.25M
9.51%-6.24M
-56.45%-4.8M
189.23%4.57M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
160.00%15.6M
120.62%6.72M
13.01%4.91M
725.16%3.97M
99.84%-3K
329.28%6M
-49.22%3.05M
968.80%4.34M
115.14%481K
62.05%-1.87M
Net issuance payments of debt
--0
--0
--0
--0
--0
71.74%-3.47M
--0
--0
--0
67.80%-3.47M
Net common stock issuance
56.13%10.04M
115,600.00%1.16M
13.01%4.91M
725.36%3.97M
--0
-7.30%6.43M
-99.98%1K
--4.34M
10.32%481K
--1.6M
Proceeds from stock option exercised by employees
82.57%5.56M
----
----
----
----
--3.05M
----
----
----
----
Net other financing activities
60.00%-4K
--0
--0
---1K
62.50%-3K
-100.37%-10K
---2K
--0
--0
-100.14%-8K
Cash from discontinued financing activities
Financing cash flow
160.00%15.6M
120.62%6.72M
13.01%4.91M
725.16%3.97M
99.84%-3K
329.28%6M
-49.22%3.05M
968.80%4.34M
115.14%481K
62.05%-1.87M
Net cash flow
Beginning cash position
-25.32%16.9M
-59.43%7.75M
-61.60%8.07M
-59.53%10.25M
-25.32%16.9M
-51.11%22.64M
-15.36%19.11M
-29.93%21.01M
-30.13%25.33M
-51.12%22.64M
Current changes in cash
-42.88%-8.19M
143.54%961K
83.49%-313K
49.47%-2.18M
-347.09%-6.65M
75.78%-5.73M
-3,840.68%-2.21M
74.38%-1.9M
31.10%-4.32M
126.79%2.69M
End cash Position
-48.45%8.71M
-48.45%8.71M
-59.43%7.75M
-61.60%8.07M
-59.53%10.25M
-25.32%16.9M
-25.32%16.9M
-15.36%19.11M
-29.93%21.01M
-30.13%25.33M
Free cash flow
-102.77%-23.79M
-9.63%-5.76M
16.31%-5.22M
-28.11%-6.15M
-245.66%-6.65M
44.28%-11.73M
11.55%-5.25M
9.57%-6.24M
-55.19%-4.8M
189.23%4.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -102.77%-23.79M-9.63%-5.76M16.31%-5.22M-28.11%-6.15M-245.66%-6.65M44.20%-11.73M11.55%-5.25M9.51%-6.24M-56.45%-4.8M189.23%4.57M
Net income from continuing operations -38.59%-24.13M-6.93%-6.31M19.45%-5.1M25.98%-5.88M-346.45%-6.83M-316.91%-17.41M-27.17%-5.9M17.15%-6.33M-128.38%-7.95M136.03%2.77M
Depreciation and amortization -37.92%352K-38.79%71K-31.71%84K-39.33%91K-40.45%106K-37.07%567K-27.95%116K-44.59%123K-45.65%150K-26.45%178K
Other non cash items --------------------100.03%10K--0--0--0-99.41%10K
Change In working capital -136.96%-1.08M214.77%554K27.01%-354K-125.06%-634K-193.04%-642K35.77%2.91M109.57%176K-348.72%-485K-32.32%2.53M1,280.00%690K
-Change in receivables --0--0--0--0--0114.78%2.5M--0--0--0354.55%2.5M
-Change in prepaid assets 41.83%217K314.38%313K-118.13%-746K-78.95%312K140.19%338K-56.90%153K46.91%-146K44.66%-342K55.67%1.48M-384.12%-841K
-Change in payables and accrued expense -296.33%-1.02M-16.71%324K710.53%464K-178.90%-879K-1.87%-926K231.47%518K-60.67%389K-108.82%-76K176.99%1.11M-13.91%-909K
-Change in other current assets 16.59%492K18.02%131K17.92%125K18.63%121K11.65%115K-35.38%422K5.71%111K1.92%106K-38.55%102K-62.95%103K
-Change in other current liabilities -12.61%-768K-20.22%-214K-13.87%-197K-11.90%-188K-3.68%-169K-286.34%-682K-12.66%-178K-13.07%-173K-117.63%-168K40.94%-163K
Cash from discontinued investing activities
Operating cash flow -102.77%-23.79M-9.63%-5.76M16.31%-5.22M-28.11%-6.15M-245.66%-6.65M44.20%-11.73M11.55%-5.25M9.51%-6.24M-56.45%-4.8M189.23%4.57M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 160.00%15.6M120.62%6.72M13.01%4.91M725.16%3.97M99.84%-3K329.28%6M-49.22%3.05M968.80%4.34M115.14%481K62.05%-1.87M
Net issuance payments of debt --0--0--0--0--071.74%-3.47M--0--0--067.80%-3.47M
Net common stock issuance 56.13%10.04M115,600.00%1.16M13.01%4.91M725.36%3.97M--0-7.30%6.43M-99.98%1K--4.34M10.32%481K--1.6M
Proceeds from stock option exercised by employees 82.57%5.56M------------------3.05M----------------
Net other financing activities 60.00%-4K--0--0---1K62.50%-3K-100.37%-10K---2K--0--0-100.14%-8K
Cash from discontinued financing activities
Financing cash flow 160.00%15.6M120.62%6.72M13.01%4.91M725.16%3.97M99.84%-3K329.28%6M-49.22%3.05M968.80%4.34M115.14%481K62.05%-1.87M
Net cash flow
Beginning cash position -25.32%16.9M-59.43%7.75M-61.60%8.07M-59.53%10.25M-25.32%16.9M-51.11%22.64M-15.36%19.11M-29.93%21.01M-30.13%25.33M-51.12%22.64M
Current changes in cash -42.88%-8.19M143.54%961K83.49%-313K49.47%-2.18M-347.09%-6.65M75.78%-5.73M-3,840.68%-2.21M74.38%-1.9M31.10%-4.32M126.79%2.69M
End cash Position -48.45%8.71M-48.45%8.71M-59.43%7.75M-61.60%8.07M-59.53%10.25M-25.32%16.9M-25.32%16.9M-15.36%19.11M-29.93%21.01M-30.13%25.33M
Free cash flow -102.77%-23.79M-9.63%-5.76M16.31%-5.22M-28.11%-6.15M-245.66%-6.65M44.28%-11.73M11.55%-5.25M9.57%-6.24M-55.19%-4.8M189.23%4.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+9.60%
Hutchmed (China)
HCM
+7.31%
eBay
EBAY
+1.88%
Enerpac Tool
EPAC
+1.56%
Halozyme Therapeutics
HALO
+1.03%

Unlock the Full List